Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical triamcinolone versus triamcinolone plus retinoic acid for symptomatic geographic tongue
IRCT201211062464N6Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Geographic tongue (BMG) comparing Topical triamcinolone acetonide monotherapy with Topical triamcinolone acetonide plus topical retinoic acid (2 arms). Started Dec 2012; status: completed.
02
Drugs
triamcinolone acetonidetretinoin
03
Conditions
Geographic tongue (BMG)
Beyond the preview
Go deeper on IRCT201211062464N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201211062464N6.